Orgovyx 120 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FJQ96
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,313
Award facts
- Contract value 100% obligated
- $8,313.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $8,313.12 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets (30-count unit dose) on August 26, 2025, with completion targeted for September 17, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. ORGOVYX is a specialized pharmaceutical product used in the treatment of advanced prostate cancer, representing the type of critical pharmaceutical commodity that supports military healthcare systems.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen maintains a significant federal procurement portfolio characterized by competitive awards of delivery orders with diverse product categories and pricing structures, demonstrating its capability to meet varied federal medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FJQ96?
SPE2DB25FJQ96 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FJQ96 worth?
The government has obligated $8,313 on SPE2DB25FJQ96.
Is contract SPE2DB25FJQ96 an order under another contract?
Yes. SPE2DB25FJQ96 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJQ96 competed?
The extent of competition for SPE2DB25FJQ96 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award